➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Boehringer Ingelheim
Moodys
Merck
McKinsey

Last Updated: September 19, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ASPIRIN; DIPYRIDAMOLE

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Aspirin; Dipyridamole

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000463 ↗ Post Coronary Artery Bypass Graft (CABG) Study Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1987-04-01 To determine the relative effectiveness of moderate versus more aggressive lipid lowering, and of low dose anticoagulation versus placebo, in delaying saphenous vein coronary bypass graft atherosclerosis and preventing occlusion of saphenous grafts of patients with saphenous vein coronary bypass grafts placed 1 to 11 years previously.
NCT00000496 ↗ Platelet Drug Trial in Coronary Disease Progression Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1979-12-01 To determine the effectiveness of the platelet inhibitor drugs dipyridamole and aspirin in reducing the angiographic progression of coronary artery disease over a five-year period and to test the predictive value of the platelet survival half-life in identifying patients with more rapid progression of coronary disease and development of its complications.
NCT00000510 ↗ Platelet-Inhibitor Drug Trial in Coronary Angioplasty Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1983-09-01 To determine the effectiveness of dipyridamole and aspirin in prevention of restenosis of the dilated lesion in patients who had undergone percutaneous transluminal coronary angioplasty (PTCA). Secondary aims were to determine the effectiveness of platelet inhibitor therapy in reducing the incidence of coronary events and the severity and incidence of angina.
NCT00000527 ↗ Recurrent Carotid Stenosis Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 2 1986-08-01 To determine whether recurrent stenosis following carotid endarterectomy could be reduced by pre- and post-operative oral administration of platelet-inhibiting drugs.
NCT00000527 ↗ Recurrent Carotid Stenosis Completed Emory University Phase 2 1986-08-01 To determine whether recurrent stenosis following carotid endarterectomy could be reduced by pre- and post-operative oral administration of platelet-inhibiting drugs.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Aspirin; Dipyridamole

Condition Name

Condition Name for Aspirin; Dipyridamole
Intervention Trials
Heart Diseases 4
Cardiovascular Diseases 4
Stroke 4
Venous Thrombosis 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Aspirin; Dipyridamole
Intervention Trials
Cardiovascular Diseases 5
Heart Diseases 4
Hypertension 4
Venous Thrombosis 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Aspirin; Dipyridamole

Trials by Country

Trials by Country for Aspirin; Dipyridamole
Location Trials
United States 48
Canada 9
Italy 5
China 4
Australia 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Aspirin; Dipyridamole
Location Trials
Tennessee 2
Oklahoma 2
New York 2
Minnesota 2
Pennsylvania 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Aspirin; Dipyridamole

Clinical Trial Phase

Clinical Trial Phase for Aspirin; Dipyridamole
Clinical Trial Phase Trials
Phase 4 8
Phase 3 8
Phase 2/Phase 3 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Aspirin; Dipyridamole
Clinical Trial Phase Trials
Completed 14
Recruiting 5
Not yet recruiting 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Aspirin; Dipyridamole

Sponsor Name

Sponsor Name for Aspirin; Dipyridamole
Sponsor Trials
Boehringer Ingelheim 6
National Heart, Lung, and Blood Institute (NHLBI) 4
Yangzhou University 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Aspirin; Dipyridamole
Sponsor Trials
Other 23
Industry 9
NIH 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Johnson and Johnson
Moodys
Merck
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.